Search results for "Retrospective Cohort Study"

showing 10 items of 1452 documents

Long-term results of surgical treatment of high myopia with Worst-Fechner intraocular lenses

1995

Abstract This retrospective study evaluated the results in 90 eyes that had a minus-power anterior chamber intraocular lens implanted to correct high myopia. Preoperative myopia ranged from −7.00 to −24.00 D. Postoperative spherical equivalent was −0.50 D; 80.5% of eyes were within 1.00 D of emmetropia. Two years postoperatively, no cataract formation, retinal detachment, glaucoma, or significant endothelial damage had occurred. We conclude that minus-power lenses can rapidly, safely, and predictably correct high myopia in phakic patients.

AdultMaleRefractive errormedicine.medical_specialtygenetic structuresAnterior ChamberEye diseasemedicine.medical_treatmentVisual AcuityEmmetropiaGlaucomaIntraocular lensProsthesis DesignVision disorderPostoperative ComplicationsOphthalmologyMyopiamedicineHumansLongitudinal StudiesAgedRetrospective StudiesLenses Intraocularbusiness.industryRetinal detachmentRetrospective cohort studyMiddle AgedPrognosismedicine.diseaseeye diseasesSensory SystemsOphthalmologyFemaleSurgerysense organsmedicine.symptombusinessFollow-Up StudiesJournal of Cataract and Refractive Surgery
researchProduct

Haematopoietic stem cell transplantation for vasculitis including Behçet's disease and polychondritis: a retrospective analysis of patients recorded …

2006

Objective: To evaluate the feasibility of haematopoietic stem cell transplantation (HSCT) in vasculitis. Methods: This is a retrospective analysis of patients who had received HSCT for vasculitic diseases and have been reported to the European League Against Rheumatism autoimmune disease or European Bone Marrow Transplantation ProMISe databases. Information about the disease and outcome was obtained by a questionnaire sent to the referring centres. Response of the disease to HSCT was defined as partial or complete responses according to the ability to reduce immunosuppression after HSCT. In addition, the Medline database was searched for reports on HSCT in patients with vasculitis. Results:…

AdultMaleReoperationVasculitisDatabases Factualmedicine.medical_treatmentMEDLINEImmunologyBehcet's diseasecomputer.software_genreTransplantation AutologousGeneral Biochemistry Genetics and Molecular BiologyRheumatologyimmune system diseasesRecurrencehemic and lymphatic diseasesmedicineImmunology and AllergyHumansTransplantation HomologousRetrospective StudiesImmunosuppression TherapyDatabasePolyarteritis nodosabusiness.industryBehcet SyndromeHematopoietic Stem Cell TransplantationRetrospective cohort studyImmunosuppressionmedicine.diseaseConnective tissue diseaseTransplantationExtended ReportEuropesurgical procedures operativeTreatment OutcomeFemalebusinessVasculitiscomputerCartilage DiseasesRheumatism
researchProduct

Use of ADCON®-L to Prevent Peridural Fibrosis Following Re-Operation for Recurrent Lumbar Radiculopathy: Clinical Results

2002

OBJECTIVE To present the results of a small retrospective study in patients after they have undergone lumbar scar resection and ADCON-L application to prevent recurrent formation of peridural fibrosis. PATIENTS AND METHODS Between May 1996 and December 1999 nineteen patients underwent surgery for peridural fibrosis. Sixteen patients were eligible for statistical analysis. The mean age was 46.2 years (range 29 to 69 years) and the mean follow-up period was 9.7 months with a range of 3 to 38 months. In 10 patients scar formation was the main factor for nerve root compression. Three out of these patients showed concomitant recurrent disc herniation. Six patients presented with peridural fibros…

AdultMaleReoperationmedicine.medical_specialtyNerve rootDecompressionCicatrixLumbarRecurrenceHumansMedicineOrganic ChemicalsRadiculopathyAgedRetrospective StudiesAdcon-Lbusiness.industryLumbosacral RegionRetrospective cohort studyGeneral MedicineMiddle AgedFibrosisSurgeryIntervertebral diskTreatment OutcomeConcomitantSurgeryDura MaterNeurology (clinical)ComplicationbusinessGelsmin - Minimally Invasive Neurosurgery
researchProduct

Revisional bariatric surgery due to failure of the initial technique: 25 years of experience in a specialized Unit of Obesity Surgery in Spain.

2019

Abstract Objectives To evaluate the effectiveness of conversion surgery in a bariatric surgery unit with 25 years of experience. Method Retrospective observational study of patients with type II obesity or higher who were reoperated by means of conversion surgery due to weight regain, residual body mass index (BMI) >35 kg/m2 or Results A total of 112 patients were included, with a mean age of 40.2 years, who initially underwent vertical banded gastroplasty (VBG) (32.1%), gastric banding (GB) (23.2%), Roux-en-Y gastric bypass (RYGB) (21.4%) and sleeve gastrectomy (SG) (23.2%). The conversion techniques, with a median time between the two surgeries of 70 months, included: RYGB, SG, one-anasto…

AdultMaleReoperationmedicine.medical_specialtySleeve gastrectomyTime FactorsGastroplastymedicine.medical_treatmentGastric BypassAftercareBariatric SurgeryComorbidity030230 surgeryWeight Gain03 medical and health sciences0302 clinical medicinePostoperative ComplicationsWeight lossGastrectomyWeight LossMedicineHumansMass indexTreatment FailurePerioperative PeriodBiliopancreatic DiversionRetrospective StudiesAnthropometrybusiness.industryMortality rateAnastomosis SurgicalGeneral EngineeringRetrospective cohort studyPerioperativeMiddle Agedmedicine.diseaseBiliopancreatic DiversionObesitySurgeryObesity MorbidSpainFemalemedicine.symptombusinessCirugia espanola
researchProduct

Questionable Value of Adjuvant Arteriovenous Fistula in Pedal Bypass at High Risk for Early Failure

2007

Results of an adjuvant arteriovenous fistula (AVF) in pedal bypass surgery in the presence of poor status of the recipient artery, severely impaired intraoperative runoff, or revision for early failure and flow restitution were analyzed in a retrospective study. From January 1998 to December 2006, 24 adjuvant AVFs were constructed in autologous vein or composite pedal bypasses with low intraoperative bypass flow, poor status of the pedal artery, or during successful early bypass revision to prevent graft failure. All infrainguinal bypass operations were registered in a computerized database and prospectively followed. Pedal bypasses with adjunctive AVF were reviewed for fistula function, gr…

AdultMaleReoperationmedicine.medical_specialtyTime FactorsFistulamedicine.medical_treatmentArteriovenous fistulaRisk AssessmentAmputation SurgicalVeinsBlood Vessel Prosthesis ImplantationArteriovenous Shunt SurgicalIschemiaOcclusionmedicineHumansVascular PatencyTreatment Failurecardiovascular diseasesVascular PatencyAgedRetrospective StudiesAged 80 and overPeripheral Vascular DiseasesLegbusiness.industryPatient SelectionGraft Occlusion VascularRetrospective cohort studyGeneral MedicineMiddle AgedLimb Salvagemedicine.diseaseSurgerybody regionsmedicine.anatomical_structureAmputationBypass surgeryFemaleSurgeryRadiologyCardiology and Cardiovascular MedicinebusinessArteryAnnals of Vascular Surgery
researchProduct

Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.

2015

Background— In the meantime, catheter ablation is widely used for the treatment of persistent atrial fibrillation (AF). There is a paucity of data about long-term outcomes. This study evaluates (1) 5-year single and multiple procedure success and (2) prognostic factors for arrhythmia recurrences after catheter ablation of persistent AF using the stepwise approach aiming at AF termination. Methods and Results— A total of 549 patients with persistent AF underwent de novo catheter ablation using the stepwise approach (2007–2009). A total of 493 patients were included (Holter ECGs ≥every 6 months). Mean follow-up was 59±16 months with 2.1±1.1 procedures per patient. Single and multiple procedu…

AdultMaleReoperationmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCatheter ablationKaplan-Meier EstimateDisease-Free SurvivalYoung AdultSex FactorsHeart RatePredictive Value of TestsRecurrenceRisk FactorsPhysiology (medical)Internal medicineHeart rateAtrial FibrillationmedicineTachycardia SupraventricularHumans610 Medicine & healthAgedRetrospective StudiesAged 80 and overbusiness.industryAtrial fibrillationRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAtrial FlutterPredictive value of testsPersistent atrial fibrillationMultivariate AnalysisCardiologyCatheter AblationElectrocardiography AmbulatoryFemaleCardiology and Cardiovascular MedicinebusinessStepwise approachAnti-Arrhythmia AgentsAtrial flutterFollow-Up StudiesCirculation. Arrhythmia and electrophysiology
researchProduct

Chronic subdural hematoma--craniotomy versus burr hole trepanation.

2009

The authors present a series of more than 200 surgical procedures for chronic subdural hematoma in a 5-year-period. Clinical presentation and neurosurgical treatment were regarded with a special focus on the surgical technique. Between March 2003 and July 2008, 193 patients (113 male and 80 female, mean age 72.5 yrs [range 26–97 yrs]) suffering from chronic subdural hematoma were retrospectively analyzed. One-hundred-fifty-one craniotomies and 42 burr holes were performed. Forty-two craniotomy patients (27.8%) in contrast to 6 burr hole patients (14.3%) required surgical revision. A craniectomy was performed as an ultima ratio after at least 2 prior evacuations in 3 cases. Chronic subdural …

AdultMaleReoperationmedicine.medical_specialtymedicine.medical_treatmentBurr holesHematomaChronic subdural hematomaRecurrenceTrephiningmedicineHumansCraniotomyAgedRetrospective StudiesAged 80 and overbusiness.industryAge FactorsRetrospective cohort studyMean ageGeneral MedicineSurgical proceduresMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeSubdural hygromaHematoma Subdural ChronicSurgeryFemaleNeurology (clinical)businessTomography X-Ray ComputedCraniotomyBritish journal of neurosurgery
researchProduct

Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study

2017

Abstract Background The association between multiple sclerosis (MS) and cancer has long been investigated with conflicting results. Several reports suggest an increased cancer risk among MS patients treated with immunosuppressant (IS) drugs. Methods We performed a cohort study including MS patients recruited at the Neurological Department of the University of Palermo. Mean follow-up period was ten years for the whole cohort. We calculated cancer incidence among patients treated with IS. Incidence rates were compared in the cohort by calculating the relative risk according to length and dose of exposure to IS. Cancer incidence among MS patients was compared to cancer incidence in the general…

AdultMaleRiskmedicine.medical_specialtyMultiple SclerosisPopulationlcsh:RC346-429Cohort StudiesYoung Adult03 medical and health sciences0302 clinical medicineNeoplasmsInternal medicinemedicineHumansMultiple sclerosiCancer; Cohort study; Immunosuppressant; Multiple sclerosis; Treatment; Neurology (clinical)Prospective cohort studyeducationlcsh:Neurology. Diseases of the nervous systemCancerImmunosuppressanteducation.field_of_studybusiness.industryIncidenceMultiple sclerosisCancerRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryTreatment030220 oncology & carcinogenesisRelative riskCohortFemaleNeurology (clinical)Cohort studybusinessImmunosuppressive Agents030217 neurology & neurosurgeryResearch ArticleCohort studyBMC Neurology
researchProduct

Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.

2009

summaryKnowledge on the natural history of mesenteric vein thrombosis (MVT) and of the efficacy and safety of long-term oral anticoagulant therapy (OAT) in this setting is based on small uncontrolled series of patients with a limited follow-up. It was the aim of the study to assess the natural history of MVT in a cohort of patients treated with OAT. The charts of all MVT patients currently attending or who have attended four anticoagulation clinics were reviewed. Information on risk factors, treatment, recurrence, major bleeding and mortality was collected. Seventyseven patients (mean age 49.2 years; 45 males) were included with a median follow-up of 36 months (range 2–204 months). Forty-si…

AdultMaleRiskmedicine.medical_specialtyVitamin Kmedicine.drug_classmedicine.medical_treatmentSettore MED/15 - Malattie Del SangueCohort StudiesRisk FactorsmedicineHumansVeinAgedRetrospective StudiesAged 80 and overVenous ThrombosisChemotherapybusiness.industryAnticoagulantAnticoagulantsRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurgeryMesenteric ArteriesNatural historyVenous thrombosismedicine.anatomical_structuremesenteric vein thrombosisCohortFemalebusinessCohort study
researchProduct

Gender differences in adverse drug reactions in dermatological patients in west Sicily: an epidemiological study

2013

Purpose: The purpose of this study was to show that gender also plays an important role in pharmacokinetics, pharmacodynamics, and drug toxicity. It is only fair to take into account the so-called “gender-based medicine.” Methods: We again selected admission for cutaneous adverse drug reaction (CADRs), from January 2012 to July 2012, in order to detect and verify, in an analytical way, the substantial gender differences in adverse drug reactions in term incidence, clinical manifestations, severity and drugs involved. Results:In the period January–July 2012, at the Department of Dermatology and Sexually Transmitted Disease of A.O.U.P. “Paolo Giaccone” Palermo, 384 patients were admitted, of …

AdultMaleSexually transmitted diseasemedicine.medical_specialtyDermatologyPharmacologySex FactorsPharmacokineticsInternal medicineEpidemiologyPharmacovigilancemedicineSettore MED/35 - Malattie Cutanee E VenereeHumansSicilyRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyadverse drug reactions gender-based medicine pharmacovigilanceMiddle Agedmedicine.diseasePharmacodynamicsFemaleDrug EruptionsbusinessAdverse drug reaction
researchProduct